<DOC>
	<DOCNO>NCT01430260</DOCNO>
	<brief_summary>This comparison efficacy ciclesonide nasal spray levocetirizine , alone combination .</brief_summary>
	<brief_title>Omnaris Versus Levocetirizine Phase 4 Study</brief_title>
	<detailed_description>randomize , open-label , three arm , parallel group , multi-center study</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Allergic rhinitis patient age ≥ 18 year ( history AR 1 year longer ) Moderate severe patient accord ARIA guideline To demonstrate positive skin prick test serologic test least 1 allergen . Subjects complete subject diary ( S ) least 70 % . Nasal pathology , include nasal polyp , clinically relevant respiratory tract malformation , recent nasal biopsy ( within 60 day ) , nasal trauma , nasal surgery , atrophic rhinitis , rhinitis medicamentosa ( within 60 day ) , asthma require corticosteroid treatment Hypersensitivity corticosteroid and/or hydroxyzine Hypersensitivity galactose intolerance , lapp lactase deficiency , glucosegalactose malabsorption A history respiratory tract infection disorder within 2 week screen visit respiratory tract infection baseline Active asthma require treatment inhale systemic corticosteroid and/or routine use βagonists Treated systemic corticosteroid ( within 8 week study initiation ) topical corticosteroid ( &gt; 1 % hydrocortisone , within 4 week study initiation ) antibiotic ( within 2 week first visit )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>efficacy</keyword>
	<keyword>ciclesonide</keyword>
	<keyword>levocetirizine</keyword>
	<keyword>allergic rhinitis</keyword>
</DOC>